ReviewFrontiers in cell and developmental biology2021

Mechanistic Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Potential, Limitations, and Perspectives.

Seraina Faes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.